Effect of intravenous pentoxifylline on oxidative stress in patients undergoing nephrolithotomy

Minerva Urologica e Nefrologica

Volumn 60, Issue 3, 2008, Pages 151-157

  Mojtahedzadeh, M ^a   Izadpanah, F ^a,b   Kazem Aghamir, S M ^a   Atharikia, D ^a   Reza Nikoobahkt, M ^a   Abbasi, A ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Catecholamines; Creatine kinase; Nephrolithotomy, percutaneous; Oxidative stress; Pentoxifylline

Indexed keywords

ADRENALIN; C REACTIVE PROTEIN; CATECHOLAMINE; CREATINE KINASE; HYDROCORTISONE; NORADRENALIN; PENTOXIFYLLINE; PLACEBO;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DROWSINESS; DRUG EFFECT; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; MALE; NAUSEA AND VOMITING; NEPHROLITHOTOMY; OPERATION DURATION; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL;

ADULT; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NEPHROSTOMY, PERCUTANEOUS; OXIDATIVE STRESS; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS;

EID: 55749090994     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hafez HM, Berwanger CS, McColl A, Richmond W, Wolfe JH, Mansfield AO et al. Myocardial injury in major aortic surgery. J Vasc Surg 2000;31:742-50.
2. Misthos P, Katsaragakis S, Theodorou D, Milingos N, Skottis I. The degree of oxidative stress is associated with major adverse effects after lung resection: a prospective study. Eur J Cardiothorac Surg 2006;29:591-5.
3. Ruzic B, Tomaskovic I, Trnski D, Kraus O, Bekavac-Beslin M, Vrkic N. Systemic stress responses in patients undergoing surgery for benign prostatic hyperplasia. BJU Int 2005;95:77-80.
4. Zulfikaroglu B. Koc M, Soran A, Isman FK, Cinel I. Evaluation of oxidative stress in laparoscopic cholecystectomy. Surg Today 2002;32:869-74.
5. Cornu-Labat G, Serra M, Smith A, McGregor WE, Kasirajan K, Hirko MK et al. Systemic consequences of oxidative stress following aortic surgery correlate with the degree of antioxidant defenses. Ann Vasc Surg 2000;14:31-6.
6. Golovanov SA, Ianenko EK, Dzeranov NK, Drozhzheva VV, Be?shliev DA, Kon'kova TA. Lipid peroxidation and antioxidant system in patients with urolithiasis after extracorporeal lithotripsy. Urol Nephrol 1998;2:14-6.
7. Rajbala A, Sane AS, Shah PR, Mishra W, Patel SM, Shah SA et al. Effect of renal transplantation (surgical stress) on serum levels oxidants and reducing system. Panminerva Med 1999;41:31-4.
8. Takahashi T, Konta T, Takasaki S, Ichikawa K, Takeishi Y, Kubota I. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy. Clin Exp Nephrol 2007;11:202-8.
9. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002;236:814-22.
10. Prasad K, Lee P. Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism. Atherosclerosis 2007;192:313-22.
11. Maiti R, Agrawal NK, Dash D, Pandey BL. Effect of Pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients. Vasc Pharmacol 2007;47:118-24.
12. Gallardo JM, Prado-Uribe MC, Amato D, Paniagua R. Inflammation and oxidative stress markers by Pentoxifylline treatment in rats with chronic renal failure and high sodium intake. Arch Med Res 2007;38:34-8.
13. Radfar M, Larijani B, Hadjibabaie M, Rajabipour B, Mojtahedi A, Abdollahi M. Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double-blind placebo-controlled clinical trial. Biomed Pharmacotherapy 2005;59:302-6.
14. Wordliczek J, Szezepanik AM, Banach M, Turchan J, Zembala M, Siedlar M et al. The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci 2000;66:1155-64.
15. Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000;85:109-17.
16. Castejón-Casado J, Moreno-Prieto M, Valladares-Mendías JC, Alaminos-Mingorance M, López-Candel E, Ramírez-Navarro A. Hormonal response to surgical stress in schoolchildren. Eur J Pediatr Surg 2001;11:44-7.
17. Naito Y, Tamai S, Shingu K, Shindo K, Matsui T, Segawa H et al. Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology 1992;77:426-31.
18. Karayiannakis AJ, Makri GG, Mantzioka A, Karousos D, Karatzas G. Systemic stress response after laparoscopic or open cholecystectomy: a randomized trial. Br J Surg 1997;84:467-71.
19. Cargnoni A, Boraso A, Scotti C, Ghirardelli N, Benigno M, Bernocchi P et al. Effect of angiotensin converting enzyme inhibition with quinaprilat on the ischemic and reperfused myocardium. J Mol Cell Cardiol 1994;26:69-86.
20. Ferrari R, Cargnoni A, Curello S, Boffa GM, Ceconi C. Effects of iloprost (ZK 30374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts. Br J Pharmacol 1989;98:678-84.
21. Moss DW, Henderson R. Clinical enzymalogy. In: Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry. 3rd ed. Philadelphia: W.B. Saunders Company; 1999. p. 617-721.
22. Coimbra R, Melbostad H, Hoyt DB. Effects of phosphodiesterase inhibition on the inflammatory response after shock: role of pentoxifylline. J Trauma 2004;56:442-9.
23. Coe DA, Freischlag JA, Johnson D, Mudaliar JH, Kosciesza SA, Traul DK et al. Pentoxyfylline prevents endothelial damage due to ischemia and reperfusion injury. J Surg Res 1997;67:21-5.
24. Yamamoto M, Shimizu M, Kawabata S. Cerebral vasodilators potentiate the anti-anoxic activity of indeloxazine hydrochloride, a new cerebral activator. Neuropharmacol 1989;28:313-7.
25. Lauterbach R, Grabowska A, Marcinkiewicz J. Effect of pentoxifylline on nitric oxide released by murine macrophages. Biol Neonate 1995;67:72-6.
26. Greten TF, Eigler A, Sinha B, Moeller J, Endres S. The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-α and nitric oxide. Int J Immunopharmacol 1995;17:605-10.
27. Noyan T, Onem O, Ramazan Sekeroglu M, Koseoglu B, Dulger H, Bayram I et al. Effects of Erythropoietin and Pentoxifylline on the oxidant and antioxidant systems in the experimental short bowel syndrome. Cell Biochem Funct 2003;21:49-54.
28. Wanchu A, Khullar M, Bhatnagar A, Sud A, Bambery P, Singh S. Pentoxiphylline reduces nitric oxide production among patients with HIV infection. Immunol Lett 2000;74:121-5.
29. Beshay E, Croze F, Prud'homme GJ. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo. Clin Immunol 2001;98:272-9.
30. Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000;85:109-17.
31. Weissman C. The metabolic response to stress: an overview and update. Anesthesiology 1990;73:308-27.
32. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985;17:291-306.
33. Remiao F, Carmo H, Carvalho FD, Bastos ML. Inhibition of glutathione reductase by isoproterenol oxidation products. J Enzyme Inhib 2000;15:47-61.
34. Bindoli A, Rigobello MP, Deeble DJ. Biochemical and lexicological properties of the oxidation products of catecholamines. Free Radic Biol Med 1992;13:391-405.
35. + transport. Arch Biochem Biophys 2001;387:85-92.
36. Maker HS, Weiss C, Brannan TS. Amine-mediated toxicity. The effects of dopamine, norepinephrine, 5-hydroxytryptamine, 6-hydroxydopamine, ascorbate, glutathione and peroxide on the in vitro activities of creatine and adenylate kinases in the brain of the rat. Neuropharmacol 1986;25:25-32.
37. Fu W, Luo H, Parthasarathy S, Mattson MP. Catecholamines potentiate amyloid beta-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol Dis 1998;5:229-43.
38. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med 2000;109:665-78.
39. Uysal F, Girgin FK, Tuzun S, Aldemir S, Sozmen EY. Effect of vitamin E on antioxidant enzymes and nitric oxide in ischemia-reperfused kidney injury. Biochem Mol Biol Int 1998;44:1255-63.
40. Remondino A, Kwon SH, Communal C, Pimentel DR, Sawyer DB, Singh K et al. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 2003;92:136-8.
41. Fujii T, Sugiura T, Ohkita M, Kobuchi S, Takaoka M, Matsumura Y. Selective antagonism of the postsynaptic alpha(1)-adrenoceptor is protective against ischemic acute renal failure in rats. Eur J Pharmacol 2007;574:185-91.